Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Hancock Whitney Corp

Hancock Whitney Corp grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 54,015 shares of the medical equipment provider's stock after acquiring an additional 950 shares during the quarter. Intuitive Surgical comprises 0.9% of Hancock Whitney Corp's investment portfolio, making the stock its 19th biggest holding. Hancock Whitney Corp's holdings in Intuitive Surgical were worth $28,194,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ISRG shares. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company's stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 35,454 shares of company stock valued at $18,564,027 in the last three months. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $6.46 during trading on Friday, reaching $514.59. The company had a trading volume of 2,015,889 shares, compared to its average volume of 1,617,024. The firm has a market capitalization of $183.29 billion, a price-to-earnings ratio of 80.28, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The stock's 50 day moving average price is $511.92 and its two-hundred day moving average price is $532.71.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.